ANTIVIRAL THERAPY OF PARENTERAL HEPATITIS IN HIV-POSITIVE PATIENTS IN PRIMORSKY KRAI
Abstract
The paper shows organisation chart of medical care to patients with combined pathology - HIV infection and chronic Virus Hepatitis B and C - in Primorsky Krai and experience in applying combined antiviral therapy (interferons and Ribavirin) for the purposes of top-priority national project "Health" during
2007-2008. In 2007 and 2008, two hundred HIV-positive patients were subject to antiviral treatment with regard to Hepatitis B and C. By the end of 2008, 168 patients were under antiviral treatment. The course of antiviral therapy for HIV-positive patients was equal to 48 weeks. By the end of January 2009, 52 patients completed the treatment of parenteral Hepatitis, among them 42 patients passed a full course, 10 patients stopped their treatment for various reasons.
2007-2008. In 2007 and 2008, two hundred HIV-positive patients were subject to antiviral treatment with regard to Hepatitis B and C. By the end of 2008, 168 patients were under antiviral treatment. The course of antiviral therapy for HIV-positive patients was equal to 48 weeks. By the end of January 2009, 52 patients completed the treatment of parenteral Hepatitis, among them 42 patients passed a full course, 10 patients stopped their treatment for various reasons.
Keywords
616.36-002-022-085.281.8:616.981.3:578.828.6(571.63)
About the Authors
Л. Скляр
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
Ю. Ли
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
И. Горелова
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
L. F. Sklyar
Vladivostok State Medical University
Russian Federation
Russian Federation
Yu. A. Li
Vladivostok State Medical University
Russian Federation
Russian Federation
I. S. Gorelova
Vladivostok State Medical University
Russian Federation
Russian Federation
References
1. Канестри В.Г., Кравченко А.В., Суворова З.К. Влияние туберкулеза и хронических вирусных гепатитов на проведение высокоактивной антиретровирусной терапии у ВИЧ-инфицированных пациентов // Эпидемиология и инфекционные болезни. 2008. № 3. С. 46-50.
2. Кравченко А.В., Ганкина Н.Ю., Канестри В.Г. Особенности антиретровирусной терапии при сочетании ВИЧ-инфекции и хронического вирусного гепатита // Фарматека. 2008. № 19. С. 1-8.
3. Покровский В.В., Ладная Н.Н., Соколова Е.В. ВИЧ-инфекция: информационный бюллетень Федерального научно-методического центра по профилактике и борьбе со СПИД Роспотребнадзора. 2008. № 31.
4. Шахгильдян В.И., Васильева Т.Е., Перегудова А.Б. Спектр, особенности клинического течения, диагностика оппортунистических и сопутствующих заболеваний у ВИЧ-инфицированных больных инфекционного стационара г. Москвы // Терапевтический архив. 2008. № 11. С. 10-17.
5. Alter M.J. Epidemiology of viral hepatitis // J. Hepatol. 2006. No. 44. P. 6-9.
Review
For citations:
, , , Sklyar L.F., Li Yu.A., Gorelova I.S. ANTIVIRAL THERAPY OF PARENTERAL HEPATITIS IN HIV-POSITIVE PATIENTS IN PRIMORSKY KRAI. Pacific Medical Journal. 2009;(4):80-82. (In Russ.)
Views:
230
Email this article 